Table 1b. VPA treatment responsive selected GO categories for upregulated differentially expressed genes (P<0.05).

Term	Count	P-value	Genes
Neuron development	24	0.002116771	EGFR, ITGA1, NTNG2, NRXN1, PRKG1, SLIT1, GPR98, ALCAM, EFHD1, NCAM2, EPHA7, SLITRK4, SLITRK3, S100B, CRB1, UNC5A, SEMA3A, BMP7, SNAP25, C1ORF187
Axonogenesis	16	0.003498804	UCHL1, NTNG2, NRXN1, SLIT1, ALCAM, NCAM2, ATOH1, EPHA7, SLITRK4, SLITRK3, S100B, UNC5A, SEMA3A, BMP7, SNAP25, C1ORF187
Vasculature development	17	0.016483196	CAV1, HTATIP2, FOXO1, ARHGAP24, CITED1, ANXA2, ANXA2P2, PROK2, HOXA3, ID1, CTGF, PLXDC1, CASP8, SEMA3C, EGF, THBS1, SCG2
Skeletal system development	21	0.009263376	EGFR, COL2A1, SPARC, ANXA2, HOXB4, DLX2, COL9A2, SOST, CHRDL1, HOXA3, HOXC4, NKX3-2, COL12A1, GPNMB, BMP7, COL11A1, BMP8B, BMP5, BMP6

The selected genes were represented corresponding to the respective GO